SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-21-186104
Filing Date
2021-06-09
Accepted
2021-06-09 09:00:34
Documents
8

Document Format Files

Seq Description Document Type Size
1 DEFA14A d137510ddefa14a.htm DEFA14A 35253
2 GRAPHIC g137510dsp2a.jpg GRAPHIC 3480
3 GRAPHIC g137510dsp2b.jpg GRAPHIC 33727
4 GRAPHIC g137510dsp2c.jpg GRAPHIC 17933
5 GRAPHIC g137510dsp2d.jpg GRAPHIC 2775
6 GRAPHIC g137510naa3.jpg GRAPHIC 707
7 GRAPHIC g137510naa5.jpg GRAPHIC 4858
8 GRAPHIC g137510naa7.jpg GRAPHIC 1251
  Complete submission text file 0001193125-21-186104.txt   126418
Mailing Address 9987 CARVER ROAD CINCINNATI OH 45242
Business Address 9987 CARVER ROAD CINCINNATI OH 45242 (513) 985-1920
Aerpio Pharmaceuticals, Inc. (Filer) CIK: 0001422142 (see all company filings)

IRS No.: 611547850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38560 | Film No.: 211004089
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences